Viewing Study NCT03853356


Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2026-03-13 @ 2:03 PM
Study NCT ID: NCT03853356
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-10
First Post: 2019-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evidence For Fusion In Spine With Orthoss®
Sponsor: Geistlich Pharma AG
Organization:

Study Overview

Official Title: Evidence For Fusion In Spine With Orthoss®
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2025-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EFFISO
Brief Summary: This study aims to evaluate the performance and safety of the Orthoss® as a bone graft extender in lumbar spondylodesis involving 1-2 levels (L4-L5 and/or L5-S1).
Detailed Description: This clinical investigation is a prospective, non-interventional, uncontrolled clinical trial, organized to generate clinical data on performance and safety of Orthoss® as a bone graft extender mixed with local bone at ratio of 1:1 and pedicle bone marrow aspirate in lumbar spondylodesis involving 1-2 levels. (Orthoss® is CE marked for this indication).

If you as a patient have a wear and tear disease of the spine, an operation serves to restore the stability of the spinal column. In order to promote a bony build-up of the lumbar spine segment (fusion), bone replacement material is used in your case as standard. The aim of this observational study is to determine fusion in order to address clinical performance of that bone replacement material.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: